UK markets open in 1 hour 39 minutes
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,408.91 +201.78 (+1.11%) CRUDE OIL
79.19 +0.24 (+0.30%) GOLD FUTURES
2,316.40 +6.80 (+0.29%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
47,431.29 +1,637.61 (+3.58%)
Ligand Pharmaceuticals Incorporated (LGND)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 71.42 |
| Open | 72.70 |
| Bid | 72.08 x 100 |
| Ask | 72.48 x 200 |
| Day's range | 70.86 - 72.70 |
| 52-week range | 49.24 - 94.57 |
| Volume | |
| Avg. volume | 179,904 |
| Market cap | 1.299B |
| Beta (5Y monthly) | 0.92 |
| PE ratio (TTM) | 23.87 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 02 Jul 2010 |
| 1y target est | N/A |
- Zacks
Zoetis (ZTS) Q1 Earnings and Revenues Surpass Estimates
Zoetis (ZTS) reports better-than-expected first-quarter results, wherein both earnings and revenues beat estimates. Shares rise.
- Zacks
Jazz (JAZZ) Q1 Earnings & Sales Fall Short of Estimates
Jazz's (JAZZ) first-quarter earnings and sales miss the mark. The company reaffirms its guidance for full-year 2024.
- Zacks
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
Moderna (MRNA) beats expectations for both earnings and sales. Management reiterates guidance to record around $4 billion from product sales in 2024.
© 2024 Yahoo. All rights reserved.